Finance

Lists
ALPEKA:BMV
Alpek SAB de CV
MX$12.65
-0.63%
(-0.080) 1D
Aug 5, 10:34:19 AM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for ALPEKA...
Open
MX$12.66
High
MX$12.88
Low
MX$12.62
Mkt. cap
26.57B
Avg. vol.
4.82M
Volume
1.39M
P/E ratio
36.79
52-wk high
MX$13.44
52-wk low
MX$8.07
EPS
MX$0.34
Shares outstanding
2.11B
No. of employees
5K
Open
MX$12.66
High
MX$12.88
Low
MX$12.62
Mkt. cap
26.57B
Avg. vol.
4.82M
Volume
1.39M
P/E ratio
36.79
52-wk high
MX$13.44
52-wk low
MX$8.07
EPS
MX$0.34
Shares outstanding
2.11B
No. of employees
5K
News stories
From sources across the web
Profile
Alpek S.A.B. de C.V., known as Alpek, is a Mexican chemical manufacturing company headquartered in San Pedro Garza García, in Nuevo León, Mexico. It is one of the largest PET and PTA producers in the Americas and the sole producer of polypropylene and caprolactam in Mexico. It is the largest business unit of the industrial conglomerate Alfa, representing 37% of its revenues for 2014. It is also the largest chemical company in Mexico according to Expansion magazine. Alpek reported revenues of $6.5 billion for 2014. It operates facilities in 21 sites in the United States, Mexico, Brazil, Argentina and Chile and employs 5,000 people. Alpek was listed on the Mexican Stock Exchange on April 26, 2012, and is a constituent of the IPC, the main benchmark index of the Mexican Stock Exchange. Wikipedia
About Alpek SAB de CV
CEOJose de Jesus Valdez Simancas
Employees5.13K
Founded1975
Headquarters-
SectorCommodity chemical
Websitealpek.com
Previous reportsAll values in MXN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MXN
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
31.07B
27.96B
29.76B
37.48B
Cost of goods sold
28.77B
26.90B
26.77B
30.30B
Cost of revenue
28.77B
26.90B
26.77B
30.30B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.31B
1.41B
1.32B
1.47B
Operating expense
2.13B
1.23B
1.36B
758.97M
Total operating expenses
30.90B
28.13B
28.14B
31.06B
Operating income
175.50M
-170.79M
1.62B
6.42B
Other non operating income
-306.02M
-174.02M
-282.59M
-277.30M
EBT including unusual items
-528.82M
-781.51M
-730.83M
5.94B
EBT excluding unusual items
-528.82M
-888.66M
951.22M
5.94B
Income tax expense
143.99M
646.34M
184.90M
1.30B
Effective tax rate
-27.23%
-82.70%
-25.30%
21.92%
Other operating expenses
813.89M
-183.82M
46.33M
-709.45M
Net income
-807.34M
-1.56B
-1.12B
4.14B
Net profit margin
-2.60%
-5.60%
-3.76%
11.05%
Earnings per share
-0.19
-0.70
-
1.53
Interest and investment income
67.06M
56.36M
32.55M
31.95M
Interest expense
-595.00M
-583.54M
-519.48M
-453.42M
Net interest expenses
-527.94M
-527.18M
-486.93M
-421.47M
Depreciation and amortization charges
-
-
-
-
EBITDA
1.45B
788.71M
2.86B
7.59B
Gain or loss from assets sale
4.97M
-91.77M
-1.62M
-123.65M
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
Google apps